134 related articles for article (PubMed ID: 19768401)
1. Generation and characterization of candidate vaccine viruses for prepandemic influenza vaccines.
O'Neill E; Donis RO
Curr Top Microbiol Immunol; 2009; 333():83-108. PubMed ID: 19768401
[TBL] [Abstract][Full Text] [Related]
2. Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine.
Jadhao SJ; Achenbach J; Swayne DE; Donis R; Cox N; Matsuoka Y
Vaccine; 2008 Mar; 26(14):1742-50. PubMed ID: 18336962
[TBL] [Abstract][Full Text] [Related]
3. Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010.
; Ampofo WK; Baylor N; Cobey S; Cox NJ; Daves S; Edwards S; Ferguson N; Grohmann G; Hay A; Katz J; Kullabutr K; Lambert L; Levandowski R; Mishra AC; Monto A; Siqueira M; Tashiro M; Waddell AL; Wairagkar N; Wood J; Zambon M; Zhang W
Influenza Other Respir Viruses; 2012 Mar; 6(2):142-52, e1-5. PubMed ID: 21819547
[TBL] [Abstract][Full Text] [Related]
4. Live attenuated vaccines for pandemic influenza.
Chen GL; Subbarao K
Curr Top Microbiol Immunol; 2009; 333():109-32. PubMed ID: 19768402
[TBL] [Abstract][Full Text] [Related]
5. Current status and progress of prepandemic and pandemic influenza vaccine development.
Leroux-Roels I; Leroux-Roels G
Expert Rev Vaccines; 2009 Apr; 8(4):401-23. PubMed ID: 19348557
[TBL] [Abstract][Full Text] [Related]
6. Vaccination against influenza: role and limitations in pandemic intervention plans.
Rebmann T; Zelicoff A
Expert Rev Vaccines; 2012 Aug; 11(8):1009-19. PubMed ID: 23002981
[TBL] [Abstract][Full Text] [Related]
7. Influenza virus surveillance, vaccine strain selection, and manufacture.
Stöhr K; Bucher D; Colgate T; Wood J
Methods Mol Biol; 2012; 865():147-62. PubMed ID: 22528158
[TBL] [Abstract][Full Text] [Related]
8. Strengthening the influenza vaccine virus selection and development process: Report of the 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at WHO headquarters, Geneva, Switzerland, 1-3 April 2014.
Ampofo WK; Azziz-Baumgartner E; Bashir U; Cox NJ; Fasce R; Giovanni M; Grohmann G; Huang S; Katz J; Mironenko A; Mokhtari-Azad T; Sasono PM; Rahman M; Sawanpanyalert P; Siqueira M; Waddell AL; Waiboci L; Wood J; Zhang W; Ziegler T;
Vaccine; 2015 Aug; 33(36):4368-82. PubMed ID: 26148877
[TBL] [Abstract][Full Text] [Related]
9. Exploring synergies between academia and vaccine manufacturers: a pilot study on how to rapidly produce vaccines to combat emerging pathogens.
Strecker T; Uhlendorff J; Diederich S; Lenz-Bauer C; Trusheim H; Roth B; Kolesnikova L; Aepinus C; Dornow R; Gerlach J; Matrosovich M; Valley U; Eickmann M; Becker S
Clin Chem Lab Med; 2012 May; 50(7):1275-9. PubMed ID: 22850059
[TBL] [Abstract][Full Text] [Related]
10. Production of pilot lots of inactivated influenza vaccine in response to a pandemic threat: an interim biosafety risk assessment.
Wkly Epidemiol Rec; 2003 Nov; 78(47):405-8. PubMed ID: 14677515
[No Abstract] [Full Text] [Related]
11. From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza.
Wood JM; Robertson JS
Nat Rev Microbiol; 2004 Oct; 2(10):842-7. PubMed ID: 15378048
[TBL] [Abstract][Full Text] [Related]
12. Pandemic influenza vaccines: meeting the supply, distribution and deployment challenges.
Hessel L;
Influenza Other Respir Viruses; 2009 Jul; 3(4):165-70. PubMed ID: 19627373
[TBL] [Abstract][Full Text] [Related]
13. Vaccines for pandemic influenza.
Luke CJ; Subbarao K
Emerg Infect Dis; 2006 Jan; 12(1):66-72. PubMed ID: 16494720
[TBL] [Abstract][Full Text] [Related]
14. Pandemic influenza and the global vaccine supply.
Fedson DS
Clin Infect Dis; 2003 Jun; 36(12):1552-61. PubMed ID: 12802755
[TBL] [Abstract][Full Text] [Related]
15. Generation and Characterization of Live Attenuated Influenza A(H7N9) Candidate Vaccine Virus Based on Russian Donor of Attenuation.
Shcherbik S; Pearce N; Balish A; Jones J; Thor S; Davis CT; Pearce M; Tumpey T; Cureton D; Chen LM; Villanueva J; Bousse TL
PLoS One; 2015; 10(9):e0138951. PubMed ID: 26405798
[TBL] [Abstract][Full Text] [Related]
16. Reference viruses for seasonal and pandemic influenza vaccine preparation.
Wood JS; Robertson JS
Influenza Other Respir Viruses; 2007 Jan; 1(1):5-9. PubMed ID: 19459278
[TBL] [Abstract][Full Text] [Related]
17. Influenza vaccines: the good, the bad, and the eggs.
Schultz-Cherry S; Jones JC
Adv Virus Res; 2010; 77():63-84. PubMed ID: 20951870
[TBL] [Abstract][Full Text] [Related]
18. Influenza pandemic preparedness action plan for the United States: 2002 update.
Strikas RA; Wallace GS; Myers MG
Clin Infect Dis; 2002 Sep; 35(5):590-6. PubMed ID: 12173135
[TBL] [Abstract][Full Text] [Related]
19. [Various sides of influenza. Part II--epidemiology, influenza surveillance and prophylaxis].
Machała MK; Brydak LB
Pol Merkur Lekarski; 2006 Sep; 21(123):277-85. PubMed ID: 17163191
[TBL] [Abstract][Full Text] [Related]
20. Selection of influenza vaccine strains and developing pandemic vaccines.
Wood JM
Vaccine; 2002 Dec; 20 Suppl 5():B40-4. PubMed ID: 12477418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
